The Impact of National Volume-Based Coronary Stent Procurement on Patients'Healthcare Costs
This paper uses a regression discontinuity design(RDD)and healthcare administrative data to assess the impact of the national volume-based coronary stent procurement policy on patients'healthcare burden.The results indicate that,following centralised procurement of coronary stents,in response to loss in profits,hospitals increase the number of coronary surgeries,as well as the use of imaging tests and high-value consumables,such as drug-coated balloons,which have not yet been affected by the centralised procurement policy.This phenomenon is more evident in tertiary hospitals.As a result,the average total cost and out-of-pocket expenditure do not decrease.The findings suggest that the physician-induced demand is one of the main reasons for the high medical burden on patients.Price controls on a single product cannot reduce excessive medical treatment and may even lead to further welfare losses.
national volume-based coronary stent procurementcoronary stentsphysician-induced demandmedical assistance equipment use
万方数据
维普
